Literature DB >> 27487368

Persistence with antipsychotics in dementia patients in Germany
.

Anke Booker, Louis Jacob, Jens Bohlken, Michael Rapp, Karel Kostev.   

Abstract

BACKGROUND/AIMS: To analyze the duration of treatment with antipsychotics in German dementia patients.
METHODS: This study included patients aged 60 years and over with dementia who received a first-time antipsychotic prescription by psychiatrists between 2009 and 2013. The main outcome measure was the treatment rate for more than 6 months following the index date.
RESULTS: A total of 12,979 patients with dementia (mean age 82 years, 52.1% living in nursing homes) were included. After 2 years of follow-up, 54.8%, 57.2%, 61.1%, and 65.4% of patients aged 60 - 69, 70 - 79, 80 - 89, and 90 - 99 years, respectively, received antipsychotic prescriptions. 63.9% of subjects living in nursing homes and 55.0% of subjects living at home also continued their treatment (p-value < 0.001).
CONCLUSION: The percentage of dementia patients treated with antipsychotics is very high.
.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27487368     DOI: 10.5414/CP202631

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  4 in total

1.  [Implementation of the German S3 guidelines on dementia in clinical practice: wish or reality?]

Authors:  H Lohmann; F Kulessa; H Holling; A Johnen; S Reul; G Lueg; T Duning
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

2.  Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis.

Authors:  Louis Jacob; Michael A Rapp; Karel Kostev
Journal:  Ther Adv Psychopharmacol       Date:  2017-03-01

Review 3.  [Treatment with psychotropic agents in patients with dementia and delirium : Gap between guideline recommendations and treatment practice].

Authors:  Walter Hewer; Christine Thomas
Journal:  Z Gerontol Geriatr       Date:  2017-01-25       Impact factor: 1.281

4.  A bitter pill to swallow - Polypharmacy and psychotropic treatment in people with advanced dementia.

Authors:  Lina Riedl; Esther Kiesel; Julia Hartmann; Julia Fischer; Carola Roßmeier; Bernhard Haller; Victoria Kehl; Josef Priller; Monika Trojan; Janine Diehl-Schmid
Journal:  BMC Geriatr       Date:  2022-03-16       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.